ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.69
+0.06 (1.07%)
Aug 7, 2026, 4:00 PM EDT - Market closed
ImageneBio Employees
ImageneBio had 17 employees as of March 31, 2026. The number of employees increased by 2 or 13.33% since the number was last reported on December 31, 2025.
Employees
17
Change
2
Growth
13.33%
Revenue / Employee
n/a
Profits / Employee
-$3,866,471
Market Cap
64.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 17 | 2 | 13.33% |
| Dec 31, 2025 | 15 | 5 | 50.00% |
| Dec 31, 2024 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| XBiotech | 87 |
| MindWalk Holdings | 77 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| Cardiff Oncology | 31 |
| Boundless Bio | 28 |
| iBio, Inc. | 20 |
IMA News
- 4 days ago - ImageneBio registers to sell 5.77M shares of common stock for holders - TheFly
- 4 days ago - ImageneBio files $200M mixed securities shelf - TheFly
- 4 days ago - ImageneBio reports Q2 EPS (63c), consensus (98c) - TheFly
- 4 days ago - ImageneBio Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - ImageneBio appoints Matt Robbins as general counsel - TheFly
- 4 weeks ago - ImageneBio Appoints Matt Robbins as General Counsel - GlobeNewsWire
- 2 months ago - Independent Medical Alliance Launches IMA Academy, Expanding Access to Expert-Led, CME-Accredited Medical Education - Business Wire
- 2 months ago - ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - GlobeNewsWire